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Section 1: Abstract 
 Development of lab on a chip technology, specifically for the colon, has great potential to 
elucidate mechanisms for chronic illness as well as to serve as a screening study for colonic 
drugs and causes for infection [1]. For this technology to be representative of the colon, the 
environment to which colonocyte cells are exposed must be similar to in-vivo conditions. Thus, 
glucose must not be present in solution, as it is not naturally found in the lumen of the colon [2]. 
This study focused on the development of a glucose-free cell culture medium. Specifically, it 
focused on removing glucose from growth-factor rich conditioned media, which is harvested 
from growth-factor producing cells that require glucose. Four methods were investigated to 
accomplish this: tangential flow filtration, enzymatic removal, centrifuge filtration, and the use 
of store-purchased growth factors. All methods were found to be effective in removing glucose 
from solution using quantitative glucose assays, and all methods tested for colonocyte growth 
were successful as observed by microscopy and cell growth assays. Centrifugation was the best 
method of the four due to its low processing time, sterility, reproducibility, moderate cost and 
lack of confounding byproducts. This glucose-free medium provides a cell culture base from 
which any metabolite may be introduced into the colon lab-on-a-chip system. This creates a 
platform for studies to investigate colonocyte metabolism as well as a more representative 
environment of in-vivo colonocyte conditions for future colon-on-a-chip technology 
development.  
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Section 2: Introduction 
In recent years, it has been discovered that the human microbiome plays a larger role in 
health and disease than previously thought. Per the journal article “Role of the normal gut 
microbiota,” “It is now well established that a healthy gut flora is largely responsible for the 
overall health of the host.” [1] The article cites irritable bowel dysfunction, irritable bowel 
syndrome, allergies, diabetes, and neurodevelopmental illnesses as conditions that may be linked 
to the microbiome [1]. Though the microbiome may play a key role in the cause of these 
diseases, according to the “Current Methods to Study Gut Microbiota” section of the article, it is 
very difficult and time consuming to collect and identify microorganisms using the methods that 
are typically practiced [1]. This is likely because the microbiota have a complicated symbiotic 
relationship with colonic environment, and the colon is an anaerobic organ [1]. Most of the 
microorganisms in the colon live in the outermost mucous layers of the colon, using the nutrients 
provided from the colons’ mucous as well as nutrients from the host’s diet to survive [1]. 
Because the microorganisms act in tandem with each other and the colon, it is difficult to 
evaluate possible links between the microbiome and disease using an in-vitro environment that is 
not nearly as complex as the colon itself.  
An arguably better way to study the behavior of these microorganisms would be to take 
advantage of the emerging “lab on a chip” technology. This technology aims to take human or 
animal cells and coax them to grow in a similar configuration to how they are found in the 
human body, forming small “organoids” or mini-organs [3]. Many journal articles and papers 
have researched and discussed this new up-coming technology. One in particular, “News 
Feature: Building benchtop human models,” discusses the anticipated advantages to using lab on 
a chip technology, including faster identification of toxic medicines before clinical trials, and the 
potential to build patient stem-cell microphysiological models for personalized healthcare. [3]. 
 To ensure that results from this lab on a chip technology are representative of the natural 
colonic environment, it is important to design all aspects of the model so they mimic in-vivo 
conditions. For the colon, this includes maintaining an anaerobic environment and ensuring that 
the chemical environment surrounding the cells is free from any substance that would not be 
feasibly found in their natural environment. 
 
6 
 These requirements pose a significant challenge, specifically in the development of media 
for cell growth. Glucose is a common energy source for cell culture. Media containing diabetic 
concentrations of glucose has previously been developed and optimized with many additives and 
growth factors to induce colonic cell growth and differentiation. However, because glucose is not 
digested in the colon in vivo but rather digested and absorbed in the small intestine before it ever 
reaches the colon, it must be removed for studies conducted on these cells to accurately reflect in 
vivo conditions [2]. Glucose cannot be omitted from the media entirely because it is needed to 
feed growth factor producing cells as a precursory step to its addition to colonic cells. Therefore, 
the glucose must be added and then removed from solution. 
 There are many different approaches to remove a specific substance from solution, and 
each has its pros and cons. Four methods of glucose removal were investigated to prepare 
glucose-free cell culture media in this study: tangential flow filtration (TFF), enzymatic glucose 
removal using glucose oxidase, centrifuge filtration, and the use of purchased growth factors in 
cell culture media. The following literature review focuses on the enzymatic glucose removal 
method as this is a previously unexplored approach to specifically remove glucose from cell 
culture media. 
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Section 3: Review of the Literature 
3.1: Glucose Oxidase and Catalase 
Aspergillus niger, the microbe that produces glucose oxidase, can be found anywhere in 
the world, typically in the soil and on decaying vegetation [4]. The fungus is the main source of 
many enzymes, including glucose oxidase [4].  
Glucose oxidase catalyzes the oxidation of glucose into gluconic acid [5]. Per the US 
Department of Agriculture, D-gluconic acid results from the oxidation of the glucose aldehyde 
group. [5]. The report describes the relationship between glucono-delta-lactone and gluconic 
acid, stating that some gluconic acid spontaneously converts into glucono delta-lactone in 
aqueous conditions [5]. However, other sources report glucono-delta-lactone as the product of 
glucose and glucose oxidase, stating that the lactone spontaneously hydrolizes to form gluconic 
acid [6]. Regardless, gluconic acid is formed from this reaction, and in aqueous form it always 
exists in equilibrium with glucono–delta-lactone [6].  
It is important to make the distinction between terminology largely referring to gluconic 
acid. As stated above, aqueous gluconic acid and glucono-delta-lactone always exist in 
equilibrium due to the hydrolyzation of glucono-delta-lactone [6]. This review ultimately aims to 
utilize gluconic acid in a physiologic environment similar to the colon. Therefore, this detail will 
be disregarded, because gluconic acid in the body would be in an aqueous form. Additionally, 
the charged ionic form of gluconic acid, which also exists in aqueous solution, is referred to as 
gluconate [7]. Gluconic acid and gluconate will be used interchangeably for the remainder of this 
review.  
The conversion of glucose to gluconic acid is important for the food industry, specifically 
in dried egg-white production [8]. This reaction allows food processors to use increased 
temperature during pasteurization, in addition to increasing the shelf life of the product and 
preventing the growth of bacteria [8]. For the removal of glucose in this product, glucose is 
oxidized with glucose oxidase, FAD/FADH2 and oxygen to gluconic acid and hydrogen 
peroxide [8]. Hydrogen peroxide is an unwanted by-product of this reaction, because in high 
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quantities it has the potential to denature the proteins in solution [8]. Thus, a second enzyme, 
catalase, is employed [8]. Catalase and two units of hydrogen peroxide produce two units of 
water and oxygen gas [8]. Using catalase and glucose oxidase at the same time can be mutually 
beneficial to the overall reaction [8]. This is because the breakdown rate of glucose with glucose 
oxidase requires oxygen, and the reaction of catalase and hydrogen peroxide replenishes this 
oxygen to the system [8]. 
 In addition to the food industry, the reaction of glucose oxidase and glucose is used in 
glucose detection kits [9]. These kits, available for purchase from molecular probes, capitalize on 
the hydrogen peroxide byproduct produced from the glucose-gluconic acid oxidation [9]. First, 
glucose oxidase breaks down glucose into gluconic acid hydrogen peroxide [9]. Next, Amplex 
Red reacts with the hydrogen peroxide with the aid of peroxidase to form Resorufin [9]. 
Resorufin is a fluorescent molecule, and its fluorescence in conjunction to a standard curve can 
be used to quantify how much glucose was present in the initial solution [9].  
 Historically, glucose oxidase has also been used to indicate blood glucose levels in blood 
glucose meters. In order to measure blood glucose levels, a patient pricks their finger and adds a 
small droplet of blood to a strip inserted into the meter [10]. The glucose in the blood reacts with 
glucose oxidase to form gluconic acid [10]. The gluconic acid then reacts with ferricyanide to 
form ferrocyanide [10]. An oxidation reaction occurs between the ferrocyanide and an electrode 
in the meter, which produces a current [10]. This current is proportional to the glucose 
concentration and is converted to a digital concentration displayed to the user [10]. As an 
alternative to glucose oxidase, the enzyme glucose dehydrogenase can also be implemented in 
blood glucose meters to the same effect [11].  
 Clearly, glucose oxidase is a very well characterized enzyme that has been used for a 
wide variety of applications, from the food industry to quantitative measurements of glucose 
levels in the blood. Because the use of glucose oxidase with glucose and its byproduct, gluconic 
acid, has been approved for human consumption, it is assumed that gluconic acid is not toxic to 
human tissue. Additionally, because glucose oxidase has been approved for quantitative high-
risk measurements such as measuring blood glucose levels, it is likely a reliable enzyme.  
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3.2: Gluconic Acid as a Fuel Source for Colonic Bacteria 
 Gluconic acid is a non-corrosive, non-volatile, non-toxic and mild organic acid [6] . It has 
an average molecular weight of 130-320 Da and is naturally found in wine and fruit juices, in 
addition to various plants, rice, meat dairy products, honey and vinegar [6]. Solutions containing 
gluconic acid have been found to be resistant to oxidation [6]. In order to produce gluconic acid, 
this article primarily discusses the glucose oxidase method [6]. It reports that to use glucose 
oxidase to this effect, the optimal pH is 5.5 and oxygen levels must be elevated [6]. It also states 
that glucose oxidase is unstable at temperatures higher than 50°C, and that its activity can be 
inhibited by accumulation of one of its products, hydrogen peroxide [6].  
 What this paper does not discuss, however, is that gluconic acid is naturally found in the 
colon and has been reported as a food source of several colonic bacteria [12]. Gluconic acid can 
be used as a prebiotic, and the majority (70%) of dietary gluconic acid is not digested in the 
small intestine and reaches the colon [12].This gluconic acid is fermented by the bacteria in the 
colon, including Lactobacillus and Bifidobacterium [12]. These bacteria, according to the paper, 
produce lactic acid and acetate from gluconic acid [12]. The lactate and acetate are then 
fermented by Megasphaera elsdenii, another bacteria strain found in the colon, to butyrate [12]. 
Butyrate has been cited as the primary food source for colonocytes in the literature [13]. 
 Furthermore, a specific metabolic pathway for gluconic acid in another common colon 
bacteria strain, Escherichia coli, has been widely studied [14]. This pathway is named Entner-
Doudoroff Metabolism [14]. As shown in Figure 1, D-gluconate is internalized into the cell using 
permeases [14]. Once inside the cell, it is converted via gluconate kinase to 6-P-Gluconate [14]. 
Then, from it either reacts with 6-PG Dehydratase and KDPG Aldolase to eventually to form 
pyruvate and undergo glycolysis, or it proceeds directly to the pentose phosphate pathway after 
reacting with 6-P-G-DeHase [14]. This is a simplified description based on Figure 1, and a more 
detailed description of this process can be found in the literature [14] .  
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 Figure 1. The Entner-Doudoroff Pathway [14] 
According to this study, gluconate is present in the mucus of the large intestine of the 
mouse at a concentration of 0.69M [14]. This concentration was deduced from high performance 
liquid chromatography and is noted as part of unpublished results [14]. The paper continues on to 
state that “In vitro growth experiments showed that 0.69 mM gluconate in minimal medium 
allows formation of 1.5 x 108 E. coli cells, which is precisely the population of E. coli cells in 
colonized mice.” [14]. This finding, in conjunction with earlier references in the paper that 
discuss that E-coli can be grown on gluconate, suggest that gluconate is a primary metabolite for 
E. Coli cells in the colon [14]. However, it is important to note that the citation for the E. Coli 
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growth data in 0.69 mM gluconate is listed as a personal communication with P. S. Cohen [14]. 
This makes it difficult to discern how this information was obtained, thus this particular finding 
may not be as reliable as other findings discussed in the article. 
3.3: Current Information on Colonocyte Gluconic Acid Metabolism 
According to a 2014 study investigating potential human enzymes involved in gluconate 
metabolism, prokaryotic gluconate metabolism is well characterized, whereas little is known 
about human gluconate metabolism [15]. This well characterized metabolism of gluconate in 
prokaryotes is through the Entner-Doudoroff pathway, as described above [14]. Though there has 
been speculation on a possible human pathway, as the study points out this pathway has not been 
established and is only widely studied in prokaryotes [15]. This study sought to find a 
gluconokinase analog in human cells, similar to the gluconokinase found in bacteria [15]. A 
genetic code for human gluconokinase was established from this study and the enzyme did break 
down gluconate, but the article concluded that “the results highlight that little is known of the 
mechanism of gluconate metabolism in humans despite its widespread use in medicine and 
consumer products.” [15] The article went on to discuss how gluconic acid can be introduced to 
the body through diet, but that outside of diet the production of gluconic acid is largely 
unaccounted for in humans [15].  
Only three papers were cited in this article discussing cellular or tissue consumption of 
gluconic acid, and all were from the 1970s or earlier. The first, a study titled “Pathways from 
gluconic acid to glucose in vitro” was conducted in 1953, and has not been replicated since then 
[16]. In this 1953 study, gluconate was radio-labeled with C14, injected intraperitoneally 
(directly into the abdomen), and its pathway through the body from injection to excretion was 
investigated in rats [16]. The study reported that a significant portion of the gluconate was passed 
through the rat’s urine completely unchanged [16]. It also found that only very small amounts of 
gluconate were utilized by the liver cells of the rat, less than 3 percent of the total dose 
administered [16]. The second paper, published in 1957, stated that gluconate is converted 
directly to 6-phosphonogluconate without an intermediate step and claimed that purified 
gluconokinase in hog tissue was recovered [17]. The third paper investigating gluconate 
metabolism in guinea pigs, written in 1973, concluded that gluconate could only be metabolized 
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in liver, kidney, brain and heart muscle tissue [18]. Colonic tissue was not investigated in this 
study [18]. It appears that few to no follow-up papers have been published to further investigate 
these claims for human tissue, because if such papers existed, it is likely that they would have 
been cited by the article discussed above. Independent gluconic acid human metabolism searches 
for this literature review confirm this limited availiability of information on human gluconate 
metabolism. 
A 2015 follow-up study to the 2014 article, titled “Kinetic Analysis of Gluconate 
Phosphorylation by Human Glucokinase using Isothermal Titration Calorimetry”, continues to 
discuss the lack of information on gluconic acid mammalian metabolism [19]. This study 
asserted that gluconate is broken down by glucokinase and generates 6-phosphonogluconate 
[19]. It also stated that even though gluconate is used for many applications including bio-fluids, 
there is a gap in knowledge on its metabolism in humans [19]. Similarly to the 2014 article on 
glucokinase, this study stated that early biochemical investigations show gluconate is 
internalized and metabolized [19]. However, to substantiate this claim it only referred to the 
1953 article discussed previously, and did not cite any more recent examples [16], [19]. 
Though both the 2014 and 2015 papers discussed above were written by the same 
authors, there have been additional articles written in the past five years that assert gluconic acid 
metabolism is not well understood [20]. For example, a 2011 article investigating plasma acetate, 
gluconate and interleukin-6 profiles during and after cardiopulmonary bypass states, “Current 
data on gluconate metabolism and toxicity in humans are limited.” [20]. Thus, there appears to 
be a lack of understanding on whether gluconate is metabolized in all human cells, including 
colonocytes, and if so, to what extent it is metabolized. Data on gluconic acid consumption for 
colonocytes could help to fill in some of these gaps in the available literature. 
3.4: Glucose Oxidase Method Development 
A portion of this project is to discover whether glucose oxidase is a viable option to 
remove glucose from cell culture media. Removing glucose using glucose oxidase has many 
benefits, including high selectivity, convenience, fast break-down and sterility. Additionally, its 
byproduct, gluconic acid, is naturally found in the colon. Though there are many pros to using 
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glucose oxidase, there are also some potential drawbacks to using this method. If gluconic acid is 
a metabolite for colonocytes, the breakdown of glucose to gluconic acid may do little to prevent 
confounding variables. This is especially true if the concentration of gluconic acid that the cells 
are exposed to is much higher than physiological concentration. Additionally, glucose oxidase 
and catalase remain in solution and cannot be removed, which may or may not become an issue.  
To thoroughly and fairly evaluate the feasibility of using glucose oxidase, several studies 
will be conducted. First the oxidation of glucose to gluconic acid must be confirmed. This may 
be accomplished using a blood glucose meter, the fluorescent Molecular Probes Amplex Red 
Glucose/Glucose Oxidase assay or both [9], [31]-[32]. Once it has been confirmed that glucose is 
broken down, the solution will be tested on cell culture. First, it will be assessed on Caco-2 
colorectal cancer cells. Also assessed will be ENR-W (EGF, Noggin, Rspondin and Wnt) control 
media with glucose that has not been broken down (see Section 4.1). Caco-2 cells will be studied 
first because they are extremely hardy and somewhat representative of colonic cells. If the Caco-
2 cells cannot survive in the cell media, it is highly unlikely that colon cells will.  
The growth of Caco-2 cells in each medium can be analyzed in a 96-well plate using 
Hoescht and Sytox Green stains in one study. Thus, this study has the potential to be expanded to 
aerobic and anaerobic conditions for multiple timepoints. Once the results for the Caco-2 cells 
are recorded, this study will be repeated on colonocytes.  
As an aside, data on the growth of Caco-2 and colon cells in gluconic acid produced from 
this study could also help to bridge the gap between gluconic acid metabolite studies prior to the 
1980s and the more recent studies investigating specific enzymes that have the potential to break 
down gluconic acid in human cells [15]-[19]. It has only been confirmed that gluconate can be 
metabolized in the liver, brain, heart and kidney of guinea pigs [18]. Due to recent findings that 
gluconic acid is naturally found in the colon, perhaps this carbon source could be utilized by 
colonic cells in some way. Though this is outside the scope of this project, future studies 
addressing this topic could open currently unexplored ground in colonocyte and gluconate 
metabolism. 
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Section 4: Methods 
4.1: Cell Culture Media 
Multiple different cell culture media were used throughout the duration of this methods 
development study. A brief description of each is below: 
Conditioned Media: Conditioned media contains the growth factors Wnt, Noggin, and 
Rspondin. To prepare the conditioned media, cell culture media with ample glucose (17.5 mM) 
is given to growth-factor producing cells. These cells consume glucose and release Wnt, Noggin, 
and Rspondin into solution. This solution is collected, and is combined with ENR-W base to 
make complete ENR-W with growth factors. The conditioned media solution has variable 
amounts of glucose depending on the growth-factor producing cell’s metabolism rate. This 
cannot be controlled from lot to lot. Final glucose concentrations of conditioned media have been 
measured at 0.1 mM and approximately 2 mM in past experiments. Because the initial solution 
given to the cells has 17.5 mM of glucose, in theory the final conditioned media could have 
glucose concentrations anywhere from 0 to 17.5 mM.  
ENR-W: Cell culture media optimized for primary colonocyte growth. ENR-W stands for EGF, 
Noggin, Rspondin and Wnt. It is comprised of approximately 50% conditioned media and 50% 
advanced DMEM/F-12 cell culture media, with the addition of some amino acids, proteins, and 
antibiotics including fetal bovine serum, penicillin and streptomycin [21]. Advanced DMEM/F-
12 has a very high glucose concentration of 17.5 mM [21].  
ENR: Essentially the same cell media formulation as ENR-W, but does not contain the growth 
factor Wnt.  
Glucose-Free ENR-W Base: This media is meant to mimic ENR-W with the absence of glucose 
and growth factors. It was prepared using glucose-free SILAC DMEM media base instead of 
advanced DMEM/F-12 similarly to ENR-W, without the addition of conditioned media [21], 
[22].  
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4.2: Tangential Flow Filtration 
 Tangential flow filtration was the first technique investigated to remove glucose from cell 
culture media. Tangential flow filtration (TFF) is a size based exclusion method [23].  
TFF works by pumping solution across the surface of a porous membrane [23]. Any 
molecules larger than the membrane molecular weight 
cutoff cannot fit through the pores and continue to flow 
down the path of the cartridge [23]. Meanwhile, smaller 
molecules are pulled through the pores with solution 
along the membrane (Fig. 2) [23]. The small molecules 
are expelled through the bottom of the cartridge as 
filtrate, while the rest of solution with large molecules 
is retained and cycles back to the sample reservoir [23]. 
Because glucose (MW 180 Da) is much smaller than 
the growth factors that need to be retained, (MW ~20-
50 kDa) this was a fitting process for glucose removal 
[25]-[28]. In comparison with more common filtration 
techniques like centrifuge filtration (Section 4.3), TFF has a 
few advantages, one of which is the capacity for larger volume processing [23]. In addition to 
high volume, protein recovery can be higher in TFF since the forces driving the filtrate through 
the filter are much lower compared to those required for centrifuge filtration, preventing the 
protein membrane adhesion [23]. 
 Figure 3 shows a diagram of the overall set-up and flow path for TFF processing. Label 
(1) shows the sample reservior for the initial sample and the retentate [23]. The sample is 
pumped by a peristaltic pump (2) into the entrance of the membrane cartridge (3) [23]. Solution 
flows across the membrane, and filtrate with small molecules is expelled through the bottom of 
the membrane due to a cross flow [23]. The retentate with the proteins of interest passes across 
the membrane and makes it to the end of the cartridge (4) [23]. The retained solution passes 
through a back-pressure valve (5) and is returned to the sample reservior (6) [23]. To ensure all 
liquid is not filtered along with the small molecules, a reservior supply of solution not containing 
the small molecule in question can be used to replenish the lost liquid [23]. This is known as 
Figure 2. Filtrate flow using tangential 
flow filtration [24] 
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diafiltration. In theory, keeping the total retained liquid volume constant ensures that the large 
molecule concentration of the final solution remains constant [23].  
 
Figure 3. Tangential flow filtration setup diagram. [23]  
 
 Figure 4 shows the assembled in-lab TFF system, with corresponding labels to the 
diagram in Figure 3. A Minimate TFF Capsule cartridge of pore size 3kDa was used to filter the 
solution [29]. Tubing was connected from the reservior through a VWR peristaltic mini-pump 
with variable flow. The other end was attached to the feed of the TFF cartrige (3). Tubing was 
also attached on one end to the retentate outlet (4), with the other end open to the sample 
reservior (6). On the retentate tubing a pressure valve was inserted (5), which could squeeze 
tubing to an adjustable level for pressure and flow rate control. A separatory funnel was placed 
above the reservior to continuously supply glucose-free media to the reservior keeping the total 
reservior volume constant.  
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Figure 4. In-lab setup of tangential flow filtration device. Labels correspond to the diagram in Figure 3. 
 
 A 25 mL aliquot of ENR-W colon cell growth media was added to the reservior. The 
solution was run through the TFF filtering system for a total of 7 hours and 50 minutes. Filtrate 
was collected in volumes of 15 mL, and was tested for total glucose content. Time points were 
recorded for each 15 mL filtrate aliquot collected. Glucose-free media was added to the reservior 
at approximately the same rate as filtrate expulsion to ensure the total solution volume remained 
constant. The final retentate solution was also tested for glucose content. All glucose testing for 
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the TFF was performed using the Molecular Probes Amplex Red Glucose/Glucose Oxidase assay 
kit [9]. 
4.3: Glucose Oxidase  
 Glucose oxidase and catalase, two enzymes commonly used to break down glucose in the 
food industry, were studied to break down glucose in ENR-W. Glucose oxidase reacts with 
glucose, oxygen and water to gluconate, with hydrogen peroxide as a byproduct in a 1:1 molar 
ratio [30] . The cytotoxic hydrogen peroxide byproduct is broken down by catalase into water 
and oxygen (Fig. 5) [30].  
 Two sources of glucose oxidase were used to investigate this method. The first source 
was supplied by the Molecular Probes Amplex Red Glucose/Glucose Oxidase assay kit [9]. A 
100 units/mL solution of glucose oxidase in 0.05M sodium phosphate reaction buffer (pH 7.4) 
was prepared from the reagents supplied in the kit. The second source of glucose oxidase was 
purchased in powder form from Sigma Aldrich (Glucose Oxidase from Aspergillus niger type 
VII lyophilized powder) [31]. This enzyme powder was added to 0.05M sodium phosphate 
reaction buffer (pH 7.4) as before to produce glucose oxidase solutions of varying 
concentrations.  
 The breakdown rates of glucose oxidase in ENR-W were investigated. To separate 1mL 
samples of ENR-W, 5, 10, and 15 units of glucose oxidase were added. It was hypothesized that 
oxygen may be a rate-limiting factor for glucose oxidase enzymatic activity in these samples, so 
two conditions were tested: high oxygen availability and low oxygen availability. High oxygen 
availability was simulated by placing each 1mL sample in a 50mL centrifuge tube laid 
horizontally. This ensured that there was a large liquid-gas surface interface through which 
oxygen could diffuse. Low oxygen availability was simulated by placing each sample in upright 
15mL centrifuge tubes, lowering the liquid-gas surface interface of the samples. The 
concentration of each sample was measured using the FreeStyle Precision Neo blood glucose 
meter (Section 4.6) every 20 minutes [32]. The study was terminated after 120 minutes.  
 One unit of glucose oxidase is predicted to break down 1µmol of glucose per minute in 
solution with excess oxygen [31]. Thus, for a 25mL sample of 17 mM ENR-W media, 3.4079 
units of glucose oxidase was required to break down all of the glucose in 60 minutes in theory. 
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To ensure all glucose was broken down, 6.815 units of glucose oxidase was added to 25mL of 
ENR-W media solution and left to react for 120 minutes. This solution, as well as ENR-W 
control, was placed on Caco-2 cells in a 96-well plate. After 24 hours, Hoescht and Sytox Green 
staining was performed on the cells, and they were imaged. The ratio of live to dead cells was 
calculated from the Hoescht and Sytox Green images.  
 Catalase powder enzyme was purchased from Sigma Aldrich (Catalase from bovine liver) 
[33]. A 0.05M sodium phosphate buffer solution was prepared at pH 7.1. Catalase was added to 
the sodium phosphate buffer to make a 1mg/ml final solution. To approximately 25mL of ENR-
W solution containing 6.815 units of glucose oxidase, 100 units of catalase (50uL 1mg/ml of 
solution) was added. The entire ENR-W + enzyme solution was left to react overnight, then was 
placed on Caco-2 cells. A row of control ENR-W cells was plated at the same time. After 72 
hours, the cells were stained with Hoescht and Sytox Green, and microscope images were taken. 
The ratio of live to dead cells was calculated and a t-test was performed to compare the two 
media solutions.  
 The same ENR-W solution containing glucose oxdase and catalase was placed on 
primary colonocyte cells grown in ENR cell media. Growth of the colonocyte cells was observed 
after 24 hours using the Sytox reen and Hoescht stains. The ratio of live to dead cells was 
calculated for each condition, and a t-test was used to determine if the two solutions were 
statistically significantly different.  
 
 
Figure 5. Glucose oxidase and catalase reaction to produce gluconate, oxygen, and water. [30] 
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4.4: Centrifuge Filtration 
 Centrifuge filtration was also investigated for glucose removal. This method is similar to 
TFF in that it can separate glucose from growth factor proteins based on molecular size. Solution 
is pushed from the upper reservior through the filter interface as the centrifuge tube spins (Fig. 6) 
[34]. Small molecules such as glucose are able to pass through the membrane pores of the filter, 
while larger molecules such as proteins cannot [35]. The final filtrate is discarded, and the 
retained protein solution is collected from the filter (Fig. 7) [35]. Final retentate volumes varied 
from 200-500 µL. To ensure complete removal of glucose, the retained solution was diluted and 
filtered for a second time using the same process [36].  
 
Figure 6. Diagram of Ultracengtrifuge Filter [34] 
 
 
Figure 7. Stepwise Ultracentrifugation Process [35] 
 
 Amicon Ultra 15-mL Centrifugal Units were ordered from EMD Millipore with a 3kDa 
molecular weight cutoff (Fig. 8)[36]. The tubes were rinsed with 1x PBS spun at 5000xg.To the 
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tubes,10-12 mL of ENR-W was added and spun at 5000xg for 60 minutes. 
The filtrate was collected and its glucose concentration was measured. 
The final volume of the retained protein solution was also collected. The 
retained protein solution was diluted with glucose-free ENR-W to its 
starting volume, and expected final glucose concentrations were 
calculated. This process was repeated with conditioned media.  
The centrifuged media that was tested on colonocytes was 
prepared slightly differently. The tubes were rinsed with 5mL of 1x PBS 
for 45 minutes at 25°C and 5000xg. Next, 10mL of ENR-W cell media 
was added to each tube, and was centrifuged for 1 hour at 25°C and 
5000xg. After 1 hour, the filtrate was aspirated and the retentate was 
resuspended in glucose-free ENR-W to a final volume of 1mL. The solution was centrifuged for 
30 minutes at the same conditions. After 30 minutes, the retentate was reconstituted to a final 
volume of 1mL and was resuspended in 9mL of glucose-free ENR-W. Glucose was added to the 
solution for a final concentration of 17 mM. The glucose was added to solution to investigate 
whether primary colonocytes could grow similarly to the control if glucose is added back into 
solution, proving that the growth factors were successfully recovered.  
 Primary mouse colonocytes were passaged into three media solutions: ENR-W control, 
glucose-free ENR-W + glucose, and glucose-free ENR-W + glucose + centrifuged proteins. 
Growth was measured qualitatively using brightfield microscopy at 4x and 10x magnification 
after three days. Cell growth was also measured quantitatively using the CellTiter-Glo 
luminescence assay (Section 4.6) [37].  
4.5: Store Bought Growth Factors 
 The growth factors Wnt and Rspondin were purchased in powder form, and were added 
to glucose-free ENR-W media base[38]-[39]. Two solutions containing different concentrations 
of each growth factor were investigated. The first contained Wnt at 60ng/mL and Rspondin at 
150ng/mL, and the second contained Wnt at 90ng/mL, Rspondin at 225ng/mL. Glucose was 
added back into each solution for a final concentration of 17.5 mM. The two growth factor media 
solutions were tested on primary colonocytes along with an ENR-W control. The cells were 
Figure 8. Amicon 
Ultra 15mL 
Centrifuge tube [36] 
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plated in each medium and growth was measured using the Cell-Titer Glo assay after three days 
(n=3).  
7.6: Quantitative Analysis Techniques 
 A FreeStyle Precision Neo diabetic glucose meter was used in to take rapid glucose 
measurements. The range of glucose concentrations within device tolerance are 1.1 - 27.8 mM 
[32]. The accuracy of the device was tested with glucose in 1xPBS solutions ranging from 1-17 
mM.  
 To take more precise glucose concentration measurements, the Molecular Probes Amplex 
Red Glucose/Glucose Oxidase assay kit was employed [9]. This assay relies on a few enzymatic 
reactions to measure the glucose in solution: glucose oxidase and peroxidase. As discussed in the 
literature review, glucose oxidase oxidizes the glucose molecules in solution and produces 
hydrogen peroxide as a byproduct. The hydrogen peroxide reacts with peroxidase along with 
Amplex Red to produce the fluorescent molecule resorufin (Fig. 9) . The fluorescence of 
resorufin is directly proportional to the amount of glucose in solution, and can be used in 
conjunction with a glucose standard curve to determine the sample glucose content. The assay 
has an upper tolerance range of 200 µM glucose, above which resorufin is converted to a non-
fluorescent molecule in the presence of excess hydrogen peroxide [9]. Thus, all samples in 
question were dilluted to an estimated concentration lower than 200 µM to ensure they were 
within the range of tolerance of the assay. Samples were prepared in a 96-well plate and were 
measured using a plate reader with excitation/emission set to 560/590 nm [9]. 
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Figure 9. Amplex Red glucose oxidase assay reaction. [40] 
 The CellTiter-Glo assay was used to quantify primary colonocyte cell growth. The assay 
measures the number of viable cells using luciferin and luciferase. First, viable cells are lysed so 
that their ATP is exposed to luciferin. Next, the luciferin reacts with ATP, oxygen, luciferase and 
magnesium and produces luminescene (Fig. 10) [37]. This luminescence was measured with a 
96-well plate reader. The average and standard deviation of the luminescence of each sample 
was reported.  
 
 
Figure 10. Cell titer glow assay reaction. [41] 
 The ratio of live to dead cells was another technique used to quantify the number of 
viable cells. Hoescht staining was used to label the nuclei of all cells present in the sample, while 
Sytox Green staining was used to label dead cells. Fluorescence microscopy was used to image 
the Hoescht stained cells using an ultraviolet (UV) filter, and a green fluorescent protein (GFP) 
filter was used to image the Sytox Green cells. Overlapping identical Hoescht and Sytox Green 
images were exported to ImageJ , and the total fluorescent Hoescht and Sytox Green areas were 
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calculated for each image [42]. The Sytox Green percent coverage was divided by the Hoescht 
percent coverage to calculate the total percent dead cells in the sample. T-tests were performed 
on samples with multiple replications to determine if the percent dead cells were statistically 
significant from each other, with a 0.05 significance level.  
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Section 5: Results 
 5.1 Blood Glucose Meter Testing 
 A diabetic blood glucose meter (Freestyle Precision Neo) was obtained for quick glucose 
concentration verification [32]. Before the meter was used on unknown glucose concentration 
samples, glucose solutions of known concentration were measured to determine the accuracy of 
the meter with non-blood glucose solutions. The measured glucose concentrations ranged from 
1.082 to 17.318 mM, and all measured concentrations were all slightly higher than the theoretical 
values (Table 1). The largest percent error was 32.3%, which is reasonable for this non-analytical 
glucose measurement tool. Per the glucose meter specifications, the readout value for samples 
less than 1.1 mM glucose concentration read ‘LO’ on the meter [32]. 
Table 1. Accuracy of blood glucose meter readings compared to glucose solutions of known values. 
Expected Glucose Concentration 
(mM) 
Measured Average 
(n=3)(mM) 
Standard Deviation (mM) % Error 
17.318 20.704 0.850 19.5 
8.659 11.463 0.116 32.3 
4.330 5.315 0.116 22.8 
2.165 2.296 0.064 6.1 
1.082 LO N/A N/A 
 
5.2 Tangential Flow Filtration (TFF) 
 Tangential Flow Filtration (TFF), as described in section 4.2, was the first glucose 
removal method investigated. To determine when all glucose had been removed from solution, 
filtrate samples were collected for every 15 mL of filtrate volume produced, and the time of 
collection for each sample was recorded. As shown in Figure 11, the initial ENR-W glucose 
concentration of filtrate was 9.86 mM, determined by the Molecular Probes Glucose/Glucose 
Oxidase assay kit [9]. After almost 2 hours, the glucose concentration of the filtrate decreased to 
0.29 mM. After an additional 2 hours, the measured glucose concentration of the filtrate was 
0.00 mM. The study was terminated after approximately 8 hours. The final retained solution 
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collected at this end point also measured 0.00 mM of glucose, indicating the complete removal 
of glucose, as shown in Figure 11.  
Figure 11. Glucose concentration of ENR-W colon cell media filtrate collected at various 
time points. 
  
 It was hypothesized that the phenol red from the basal growth media could be used as an 
indicator for glucose levels in the TFF filtrate and retentate, as it is also a small molecule well 
below the molecular weight cut off of the TFF cartridge filter (MW=354.376 Da) [43]. Figure 12 
shows the corresponding phenol red absorbance at 552 nm for each filtrate volume that was 
collected. At approximately 2 hours, the phenol red absorbance was 0.0874 AU, which was close 
to the absorbance of the unfiltered initial solution, 0.1169 AU. After approximately 4 hours, the 
absorbance was reduced to 0.0219 AU. At the termination of the study, the final absorbance was 
close to zero at 0.018 AU.  
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Figure 12. Phenol Red absorbance of ENR-W colon cell media filtrate collected at various time points. 
 
5.3 Glucose Oxidase 
 The glucose oxidase enzymatic method is described in section 4.3. To investigate glucose 
breakdown rates, glucose oxidase enzyme was added to three different ENR-W solution in unit 
concentrations of 5, 10, and 15 units respectively. To determine the effect of oxygen on the rate 
of the glucose oxidase enzymatic reaction, solutions of ENR-W containing glucose oxidase were 
stored in tubes held at various angles to change the surface area of the liquid/gas interface during 
the reaction. Figure 13 shows the change in concentration over time of glucose in 1 mL volumes 
that were stored upright in a 15 mL centrifuge tube to simulate an environment with low oxygen 
diffusion through solution There was little change observed in the reaction rate in response to a 
change in enzyme unit concentration. After 2 hours, the final glucose concentration of each 
solution was 10.56 mM for 5 units, 8.56 mM for 10 units, and 7.83 mM for 15 units. Figure 14 
shows glucose breakdown in 1 mL volumes of ENR-W that were stored horizontally in a 50 mL 
centrifuge tube simulating an environment with high oxygen diffusion through solutions with 5, 
10 and 15 units of glucose oxidase. The glucose breakdown under this configuration occurred at 
a much higher rate than that observed in low oxygen. Each solution had glucose concentrations 
below the limit of detection of the glucose meter (1.1 mM) after 2 hours.    
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Figure 13. Breakdown of glucose in cell culture media by glucose oxidase over time with varying 
concentrations of enzyme. A low liquid/gas interface surface area was used to simulate a low 
oxygen environment. 
 
 
Figure 14. Breakdown of glucose in cell culture media by glucose oxidase over time with varying 
concentrations of enzyme. A high liquid/gas interface surface area was used to simulate a high 
oxygen environment. 
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 The effects of glucose oxidase in ENR-W media on cell growth were evaluated using Caco-
2 cells. Cells were grown in ENR-W and compared to cells grown in ENR-W plus 0.3 units/mL 
of glucose oxidase for 24 hours. Figure 15 shows the fluorescent image of each sample treated 
with live/dead stains. The percent cell death ws quantified using imaging software to compare 
the area coverage of dead cells versus the area coverage of all cells. This calculation showed 
that in the ENR-W control only about 6% of cells died after 24 hours, and about 79% of the 
cells died in the presence of glucose oxidase. 
 
 
 
Figure 15. Left Image: Caco-2 cell growth in ENR-W + glucose oxidase media Right Image: Caco-2 
cell growth in ENR-W (control). Both images taken at 4x magnification. Red=all cells; Green=dead 
cells.  
 
The low viability of cells in the media with glucose oxidase is likely due to the increase 
in hydrogen peroxide, a side product of the glucose oxidase/glucose reaction. To break down the 
hydrogen peroxide, catalase was added to the glucose free solution. This new medium was 
evaluated using Caco-2 cells. Figure 16 shows the fluorescent image of this cell culture versus a 
control culture after 24 hours and treated with live/dead stains. Analysis of the fluorescent area 
coverage of dead cells compared to all cells revealed that only 0.30 ± 0.04% of Caco-2 cells died 
in 0.3 units of glucose oxidase/mL ENR-W plus catalase (100 units), which is similar to the 
ENR-W control, which had 2.40 ± 0.96% dead cells. A t-test of the two conditions yielded a p-
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value of 0.064, indicating that they are not statistically significantly different from each other at 
α = 0.05. It is possible that the cells used gluconic acid, the byproduct of the glucose oxidase 
reaction, as a metabolite to survive in the absence of glucose.  
 
 
Figure 16. Left Image: Caco-2 cell growth in ENR-W + glucose oxidase media with the addition of 
catalase. Right Image: Caco-2 cell growth in ENR-W (control). Both images taken at 4x magnification. 
Red=all cells; Green=dead cells. 
 
  
In addition to testing the catalase treated media on Caco-2 cells, this media was also 
evaluated as a growth media for mouse primary colonocytes. Figure 17 shows the fluorescent 
images of these cultures treated with live/dead stains after 24 hours. The ENR-W+ Glucose 
Oxidase + Catalase solution resulted in 32.69 ± 16.36% cell death, which was similar to the ENR 
media control of 32.38 ± 4.21% cell death after 24 hours. A t-test of the two conditions yielded a 
p-value of 0.978, indicating that they are not statistically significantly different from each other 
at α = 0.05. See Table 2 for a summary of cell growth in each enzymatic medium.  
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Figure 17. Left Image: Primary mouse colon cell growth in ENR-W + glucose oxidase media with the 
addition of catalase. Right Image: Primary mouse colon cell growth in ENR-W (control). Both images 
taken at 4x magnification. Red=all cells; Green=dead cells.  
 
Table 2. Summary of cellular responses to enzymatic media.  
Enzyme Media Type 
Percent Cell Death 
Enzyme Media Control Media Statistical Difference? 
ENRW + Glucose 
Oxidase (Caco-2 cells) 
78.79% 5.58% N/A (n=1) 
ENRW + Glucose 
Oxidase + Catalase 
(Caco-2 cells) 
0.30 ± 0.04% 2.40 ± 0.96% No 
ENRW + Glucose 
Oxidase + Catalase 
(mouse primary 
colonocytes) 
32.69 ± 16.36% 32.38 ± 4.21% No 
 
 
5.4 Centrifuge Filtration 
 In this method, ENR-W and conditioned media solutions were centrifuged using an 
Amicon Ultracentrifuge cartridge of pore size 3kDa to remove glucose and retain growth factor 
proteins that can be spiked into glucose free media (Section 4.4). The Amplex Red 
Glucose/Glucose Oxidase assay was employed to determine whether ultracentrifugation 
effectively removed glucose from the conditioned media solution [9]. Table 3 shows the results 
of the assay on conditioned media before and after centrifuge filtration. This method reduced the 
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glucose concentration from 0.1 mM to 0 mM in conditioned media. Prior to this approach, ENR-
W complete media was treated for the removal of glucose, however, it is important to note that 
conditioned media, not ENR-W was used in this particular centrifuge filtration study. This is 
because centrifuging conditioned media is a more efficient and cost-effective way to make the 
glucose-free media than using complete ENR-W media.  
Table 3. Glucose concentration of conditioned media and centrifuged conditioned media using Amplex 
Red Assay 
Glucose Concentration 
Sample Theoretical (mM) Measured (mM) 
1:1:1 Conditioned Media 0-17.5 0.10 
1:1:1 Conditioned Media Centrifuge Filtered 0-0.02 0.00 
 
 The data presented in Table 4 shows that the centrifugation method was able to achieve a 
25x reduction in glucose concentration in ENR-W media. It is important to note that the final 
glucose concentration was calculated assuming that the filtrate glucose concentration was 
equivalent to the starting concentration. As seen in the table, the starting concentration is very 
close to but not exactly the same as the initial glucose concentration. This may be due to the 
accuracy of the blood glucose meter. The data from Tables 3 and 4 indicate that conditioned 
media as well as ENR-W may be centrifuged to remove glucose and retain proteins, although 
conditioned media is preferable. 
Table 4. Filtration of glucose in ENR-W using ultracentrifugation method. Maximum glucose 
concentrations of the final solution were calculated based on the filtrate glucose concentrations.  
Centrifuged ENR-W Media 
Volume ENR-W 
Centrifuged (mL) 
Initial glucose  
[ ] ( mM) 
Measured Filtrate 
glucose [ ] ( mM) 
Retentate Volume 
(mL) 
Predicted Final 
Maximum Glucose [ ] 
(mM) 
12mL 15.707 15.623 0.500 0.654 
10mL 15.707 16.289 0.250 0.393 
  
A major concern for the centrifuge filtration method is the adsorption to and recovery of 
the growth factor proteins from the filtration cartridge. To demonstrate the recovery of the 
proteins from the cartridge, a solution of glucose free ENR-W was prepared using the retentate 
of the centrifuge filter process and used to culture mouse primary colonocytes. The viability of 
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cells grown in this medium was compared to viability of cells grown in ENR-W (positive 
control) and glucose free media without any growth factors (negative control). Glucose free 
medias were supplemented with 17 mM glucose to mimic the glucose concentration in typical 
ENR-W. Figure 18 shows bright field images of each culture after 3 days in both 4x and 10x 
magnifications. Typical morphology and cell viability was demonstrated in cultures with the 
ENR-W control and glucose-free ENR-W + filtered proteins with supplemented glucose medias. 
No cell growth was observed in the glucose-free ENR-W + glucose solution. 
 
 
Figure 18. Mouse primary colonocyte growth after three days in ENR-W control media, glucose-free ENR-
W base media with centrifuged proteins and 17 mM glucose, and glucose-free ENR-W base with only 17 
mM glucose.  
 Figure 19 offers a quantitative analysis of the cell growth in each of the three media 
solutions evaluated in Figure 18. A CellTiter Glo assay was used as a proxy to indicate cell 
number in each of the three conditions 3 days after plating the cells (n=3 replications) [ ]. The 
cell luminescence of the ENR-W control media was 78026.74 ± 6134.57 RLU. The cell 
luminescence of the glucose free ENR-W+ Glucose + Centrifuged Proteins media was 48756.02 
± 2982.231 RLU. The cells in the glucose free ENR-W + Glucose solution only had a relative 
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luminescence of 3213.51±1114.95 RLU. The number of cells in the glucose free media with 
filtered growth factors is a little more than half of that in the ENR-W sample. This is possibly 
due to a loss in recovery of the protein from the filter cartridge or a difference in the basal media 
compositions. Though all values are more than one standard deviation from each other, the 
glucose free ENR-W+ glucose solution without growth factors clearly has little to no growth, as 
its fluorescence is an order of magnitude smaller than the other two cultures. This data matches 
the qualitative observations presented in Figure 18.  
 
  
Figure 19. Primary mouse colon cell growth of centrifuged media indicated by the 
cell titer-glow assay. Higher fluorescence corresponds to increased cell 
concentrations. 
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5.5 Purchased Growth Factors 
 Purchased growth factors at varying concentrations were used to make glucose free 
complete ENR-W in lieu of conditioned media. The CellTiter Glo assay results from cells 
cultured in two different concentrations of growth factors as well as an ENR-W control are 
shown in Figure 20. The ENR-W control cells had a luminescence of 62522.51 ± 3835.23 RLU, 
whereas the Wnt 60ng/mL Rspondin 150ng/mL cells had a luminescence of 27855.53 ± 1635.60 
RLU. The Wnt 90ng/mL Rspondin 225ng/mL cells had a luminescence of 47193.47 ± 3786.22 
RLU. This is within one standard deviation of the glucose-free ENR-W + glucose + centrifuged 
proteins cell data shown in Figure 19, which had a fluorescence of 48756.02 ± 2982.231 RFU. 
All cell cultures were still viable after 4 days and validate that purified proteins (Wnt, Noggin, 
Rspondin) are an alternative source of growth factors to conditioned media. 
 
 
Figure 20. Primary mouse colon cell growth measured by the cell titer-glow assay in 
ENR-W with purchased growth factors. Higher fluorescence corresponds to increased 
cell concentration. 
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5.6 Summary Comparison of Methods 
 Table 5 shows a comparison of each glucose-free media preparation. Green shaded boxes 
indicate favorable, yellow indicate neither favorable nor unfavorable, and red boxes indicate 
unfavorable for each parameter considered. From this analysis, the Tangential Flow Filtration 
method appears to be the most unfavorable method followed by the glucose oxidase method. The 
centrifuge filtration and purchased growth factors methods tie for the most favorable qualities. 
However, the centrifuge filtration method is less expensive than the purchased growth factor 
method, making it the most favorable technique for media preparation. See discussion (Section 
6) for a more thorough analysis.  
 
Table 5. Qualitative Analysis of each glucose free media preparation method, based on sections 5.2-5.5.  
Critical 
Parameter 
Tangential 
Flow 
Filtration 
Glucose 
Oxidase 
Centrifuge 
Filtration 
Purchased 
Growth Factors 
Confounding 
Byproducts 
Little/None Gluconic Acid Little/None Little/None 
Sterility Low Good Good Good 
Reproducibility Medium Medium Good Good 
Cost Medium Low Medium High 
Process Time High Low Low Low 
Glucose 
Removal 
Good Good Good Good 
Cell Growth Unknown Good** Good Good 
**glucose oxidase tests were done in colonocytes grown in ENR, where glucose oxidase media was 
placed on cells and growth was observed after 24 hours. This differs from the centrifuge filtration and 
purchased growth factor tests, where the colonocytes were plated in the respective medias.  
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Section 6: Discussion 
 Multiple processes for the preparation of glucose-free media were evaluated for 
practicality, cost, and completeness. Though all methods effectively removed glucose from cell 
culture solution, some methods were preferable to others (Table 5). The most preferable method 
was found to be centrifuge filtration, followed by purchased growth factors, enzymatic glucose 
removal, and TFF. 
 Tangential flow filtration features many attractive qualities for glucose removal, 
including low flow rate to prevent protein aggregation and adsorption to the filter membrane 
during filtration, and the capability to filter larger volumes of liquid [23]. In practice, however, 
this method was time consuming, unsterile, and moderately costly. In addition to taking 4.5 
hours to filter a mere 25mL, the process was laborious and required continuous monitoring. The 
rate of filtrate production changed often over time, so to keep the retentate volume constant, the 
addition rate of glucose-free media was adjusted frequently. A cause of this filtrate production 
change could have been protein adsorption and aggregation on the pores of the membrane due to 
the cross-flow pressure of the system. An additional challenge with TFF was that the apparatus 
was too large to practically fit into a standard cell culture hood, raising the likelihood of 
contamination. Overall, the process was moderately but not unreasonably costly, with the 
cartridge costing a little more than $200; however, the reusability of the cartridge was not 
evaluated [29]. Though TFF was a viable option for removing glucose from cell culture media, 
these factors combined made it one of the more impractical methods of the four processes 
investigated. 
Another evaluated method was the enzymatic removal of glucose. This process utilized 
glucose oxidase and was predicted to be low-cost, fast, well-characterized for glucose 
breakdown, and easily performed in a cell culture hood. Glucose oxidase broke down glucose 
from a starting concentration of 14.11 mM to a final concentration of less than 1.1 mM (Fig. 13), 
as determined by the blood glucose meter.  
In cultures of Caco-2 cells, ENR-W growth media prepared with glucose oxidase 
appeared to kill most of the cells (Fig. 15). This was likely because each mole of glucose reacted 
with glucose oxidase to produce one mole of hydrogen peroxide. Thus, the final solution 
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contained up to 17.5 mM of hydrogen peroxide, causing significant cell death. Once catalase was 
added to the solution to eliminate hydrogen peroxide, however, the Caco-2 cells survived equally 
as well as the cells in ENR-W (Fig. 16) Primary mouse colon cells in the media-enzyme mixture 
also lived equally as well as the ENR-W control cells as seen in Figure 17. Unlike later cell 
growth experiments, these cells were not plated in the enzyme mixture, but rather the media was 
placed on already stable cell patches and survival was observed after 24 hours. This means that 
although there may have been glucose present in the collagen to sustain cell growth, it did show 
that the processed media did not cause any additional cell death compared to the control. 
 A complication encountered with the glucose oxidase method was the oxygen 
concentration in solution. As shown in Figure 5, oxygen is one of the reactants required for the 
glucose oxidase reaction. In cell culture media, the glucose oxidase reaction quickly exhausted 
the dissolved oxygen supply. Thus, a limiter of the reaction was the oxygen diffusion rate from 
air into the sample. This can be shown in Figures 13 and 14, where 1mL solutions containing 
glucose oxidase with low surface area exposed to the air reacted much more slowly than 1mL 
solutions with high surface areas exposed to the air. Due to the dependence on oxygen, the 
reaction environment should be considered prior to each study to ensure that the reaction goes to 
completion 
However, the largest complication of the glucose oxidase method, which was initially 
assumed to be a positive quality of the method, was the production of the byproduct gluconate. 
As discussed in the literature review, gluconate is naturally found in the colon and likely serves 
as a food source to the microbiome [12], [14]. Thus, it is something that lumen-side of 
colonocytes should naturally be exposed to, unlike glucose. Despite numerous papers outlining 
the metabolism of gluconate in bacteria,  very few studies have investigated the metabolism of 
gluconate in mammalian cells. Therefore, the potential metabolism of gluconate by primary 
colonocytes is possible but unknown [19]. Because the primary mouse colonocytes and Caco-2 
cells were able to survive equally as well in the enzyme media solution as the control, there is a 
chance that they were able to metabolize gluconate. Unfortunately, the presence of gluconate as a 
colonocyte metabolite in the final solution would render the media useless for future metabolite 
studies, as it would become a confounding variable, similar to the glucose in the starting 
solution. So, even though glucose oxidase was able to break down glucose and sustain primary 
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colonocyte growth, the method has low practicality due to the presence of the gluconate by-
product. Additionally, it is unknown if other by-products could form due to glucose oxidase 
reactions with other media components. 
The simplest solution for creating glucose-free cell media with growth factors was to use 
glucose-free media base and add pure purchased growth factors. As shown in Figure 20, primary 
mouse colonocyte growth using purchased growth factors was sustained after 3 days. Though 
this was the most straight forward method, the sheer cost of purchased growth factors makes it 
unsustainable for producing large quantities of glucose-free media. Just 1mg of Wnt growth 
factor costs $19,500, and this does not include the cost of Rspondin ($3,000/1mg) and Noggin 
($3,900/1mg) [38]-[39], [44]. It is also important to consider that with each purchase of growth 
factors an unknown portion of the factors are inactive, and this varies from lot to lot. Thus, this 
method would require time intensive assays or multiple growth factor concentration experiments 
on cells every time a new lot is prepared, wasting time, resources, and some of the expensive 
growth factors in question. 
Centrifuge filtration was deemed to be the best method for creating glucose-free media 
because of its ability to quickly and easily isolate growth factors from conditioned media without 
confounding byproducts at a relatively low cost. As shown in Tables 2 and 3, it was an effective 
method for removing glucose from ENR-W and conditioned media. Additionally, the growth 
factors in each media were shown to be recovered from the process, as indicated from the 
primary mouse colonocyte growth in Figures 18 and 19. Also, cell media solution can be easily 
transferred to the tubes in a cell culture hood. There is some cost to purchasing the 
ultracentrifuge filter tubes for this process (~$13.00/tube), but preliminary tests have indicated 
that the filters can be re-used multiple times to centrifuge 40 mL of solution total per tube [36]. 
Pricewise, this is a much more feasible and attractive option than purchasing growth factors, 
which could cost upwards of $26,000 for every 1mg of growth factors used.  
Although the centrifugation method was found to be the most practical, additional 
experiments will be conducted to further optimize this process. Preliminary experiments have 
shown that the filters can be successfully re-used, and this practice should be investigated in 
more detail. The amount of protein that is lost through adsorption to the filter membrane for each 
use is unknown. An assay of growth factors before and after centrifuging could provide valuable 
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information regarding the lifetime of the centrifuge cartridge. Additionally, an assay would allow 
media to be prepared with the same number of growth factors to maintain consistency in the 
glucose-free media from lot to lot. This would help to rule out the presence of possible 
confounding factors in future experiments due to differing amounts of growth factors in solution.   
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Section 7: Conclusion 
 The purpose of this project was to develop a glucose-free cell culture medium to better 
emulate the glucose-free natural colonic environment, as well as to create a platform from which 
other metabolites may be tested on colonocyte cells. Four methods were investigated to this end: 
tangential flow filtration, use of the enzyme glucose oxidase, centrifuging, and the use of 
purchased growth factors. Though all methods were successful in removing glucose and the 
media created from most of these methods exhibited cell growth, the centrifugation method was 
deemed superior due to its low processing time, sterility, cost, simplicity and reproducibility. 
However, there are still unknowns surrounding the centrifugation process that need to be 
explored, including the ability to reuse the centrifuge filtration tubes and quantification of 
successfully recovered growth factors. Despite these challenges, the centrifugation method 
shows great promise and has already been implemented in preliminary metabolite studies since 
its development. With the development of this unique cell culture media, colon-on-a-chip-
technology is one step closer to mimicking that of the natural environment. This will drive the 
development of treatments for deadly infectious diseases, as well as aid in enhancing the breadth 
of knowledge of the gastrointestinal system for generations to come. 
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